206 related articles for article (PubMed ID: 26159201)
1. Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JB
Curr Alzheimer Res; 2015; 12(8):745-51. PubMed ID: 26159201
[TBL] [Abstract][Full Text] [Related]
2. Gene mutations in a Han Chinese Alzheimer's disease cohort.
Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
[TBL] [Abstract][Full Text] [Related]
3. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
Gerrish A; Russo G; Richards A; Moskvina V; Ivanov D; Harold D; Sims R; Abraham R; Hollingworth P; Chapman J; Hamshere M; Pahwa JS; Dowzell K; Williams A; Jones N; Thomas C; Stretton A; Morgan AR; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Morgan K; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Johnston JA; Holmes C; Mann D; Smith AD; Love S; Kehoe PG; Hardy J; Mead S; Fox N; Rossor M; Collinge J; Maier W; Jessen F; Kölsch H; Heun R; Schürmann B; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Hüll M; Rujescu D; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Davies G; Harris SE; Starr JM; Deary IJ; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Carrasquillo MM; Pankratz VS; Younkin SG; Jones L; Holmans PA; O'Donovan MC; Owen MJ; Williams J
J Alzheimers Dis; 2012; 28(2):377-87. PubMed ID: 22027014
[TBL] [Abstract][Full Text] [Related]
4. A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.
Dong J; Qin W; Wei C; Tang Y; Wang Q; Jia J
J Alzheimers Dis; 2017; 57(2):613-623. PubMed ID: 28269784
[TBL] [Abstract][Full Text] [Related]
5. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease.
Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Al-Sarraj S; Niblock M; Gallo JM; Adnan J; Killick R; Brown KS; Medway C; Lord J; Turton J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
Neurobiol Aging; 2014 Dec; 35(12):2881.e1-2881.e6. PubMed ID: 25104557
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations.
Ikeuchi T; Kaneko H; Miyashita A; Nozaki H; Kasuga K; Tsukie T; Tsuchiya M; Imamura T; Ishizu H; Aoki K; Ishikawa A; Onodera O; Kuwano R; Nishizawa M
Dement Geriatr Cogn Disord; 2008; 26(1):43-9. PubMed ID: 18587238
[TBL] [Abstract][Full Text] [Related]
7. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
8. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
[TBL] [Abstract][Full Text] [Related]
9. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
Carboni L; Lattanzio F; Candeletti S; Porcellini E; Raschi E; Licastro F; Romualdi P
Neurosci Lett; 2015 Sep; 605():44-8. PubMed ID: 26275347
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.
Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JB
Mov Disord; 2014 Nov; 29(13):1606-14. PubMed ID: 24375821
[TBL] [Abstract][Full Text] [Related]
11. Novel PSEN1 mutations (H214N and R220P) associated with familial Alzheimer's disease identified by targeted exome sequencing.
Piccoli E; Rossi G; Rossi T; Pelliccioni G; D'Amato I; Tagliavini F; Di Fede G
Neurobiol Aging; 2016 Apr; 40():192.e7-192.e11. PubMed ID: 26925509
[TBL] [Abstract][Full Text] [Related]
12. Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.
Giau VV; Bagyinszky E; Yang YS; Youn YC; An SSA; Kim SY
Sci Rep; 2019 Jun; 9(1):8368. PubMed ID: 31182772
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer's Disease.
Giau VV; Senanarong V; Bagyinszky E; An SSA; Kim S
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917570
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.
Farnsworth B; Peuckert C; Zimmermann B; Jazin E; Kettunen P; Emilsson LS
J Alzheimers Dis; 2016 May; 53(1):209-19. PubMed ID: 27163826
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
Nudelman KNH; Jackson T; Rumbaugh M; Eloyan A; Abreu M; Dage JL; Snoddy C; Faber KM; Foroud T; Hammers DB; ; Taurone A; Thangarajah M; Aisen P; Beckett L; Kramer J; Koeppe R; Kukull WA; Murray ME; Toga AW; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu JC; Mendez M; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Wolk DA; Carrillo MC; Dickerson BC; Rabinovici GD; Apostolova LG;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S64-S73. PubMed ID: 37801072
[TBL] [Abstract][Full Text] [Related]
16. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression.
Theuns J; Del-Favero J; Dermaut B; van Duijn CM; Backhovens H; Van den Broeck MV; Serneels S; Corsmit E; Van Broeckhoven CV; Cruts M
Hum Mol Genet; 2000 Feb; 9(3):325-31. PubMed ID: 10655540
[TBL] [Abstract][Full Text] [Related]
17. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
[TBL] [Abstract][Full Text] [Related]
18. Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort.
Jin SC; Pastor P; Cooper B; Cervantes S; Benitez BA; Razquin C; Goate A; ; Cruchaga C
Alzheimers Res Ther; 2012 Aug; 4(4):34. PubMed ID: 22906081
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample.
van Duijn CM; Cruts M; Theuns J; Van Gassen G; Backhovens H; van den Broeck M; Wehnert A; Serneels S; Hofman A; Van Broeckhoven C
Eur J Hum Genet; 1999; 7(7):801-6. PubMed ID: 10573013
[TBL] [Abstract][Full Text] [Related]
20. DGGE method for the mutational analysis of the coding and proximal promoter regions of the Alzheimer's disease presenilin-1 gene: two novel mutations.
Aldudo J; Bullido MJ; Valdivieso F
Hum Mutat; 1999; 14(5):433-9. PubMed ID: 10533070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
